Effects of peroxisome proliferator-activated receptor (PPAR)-α and PPAR-γ agonists on glucose and lipid metabolism in patients with type 2 diabetes mellitus

被引：0
|
作者：
M. Bajaj
S. Suraamornkul
L. J. Hardies
L. Glass
N. Musi
R. A. DeFronzo
机构：
[1] University of Texas Health Science Center,Diabetes Division, Department of Medicine
[2] Baylor College of Medicine,Endocrinology Division
来源：
Diabetologia | 2007年 / 50卷
关键词：
Adiponectin; Insulin sensitivity; PPAR-α; PPAR-γ; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1723 / 1731
页数：8
相关论文
共 50 条
  • [31] PPAR-α and PPAR-γ agonists for type 2 diabetes
    Charbonnel, Bernard
    LANCET, 2009, 374 (9684): : 96 - 98
  • [32] PAI-1 deficiency prevention of type 2 diabetes mellitus (DM) is linked to adiponectin and peroxisome proliferator-activated receptor-γ (PPAR-γ).
    Ma, LJ
    Mao, SL
    Guan, YF
    Zhang, YH
    McGuinness, OP
    Swift, LL
    Wasserman, D
    Fogo, AB
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 168A - 169A
  • [33] Peroxisome proliferator-activated receptor gamma (PPARγ):: Molecular study in glucose homeostasis, lipid metabolism and therapeutic approach
    Tavares, Vladimir
    Hirata, Mario Hiroyuki
    Hirata, Rosario D. Crespo
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2007, 51 (04) : 526 - 533
  • [34] Peroxisome proliferator-activated receptor (PPAR α/γ) agonists as a potential target to reduce cardiovascular risk in diabetes
    Nicholls, Stephen J.
    Uno, Kiyoko
    DIABETES & VASCULAR DISEASE RESEARCH, 2012, 9 (02): : 89 - 94
  • [35] Evidence for differential effects of glucose and cycloheximide on mRNA levels of peroxisome proliferator-activated receptor- (PPAR-) machinery members: Superinduction of PPAR-γ1 and -γ2 mRNAs
    Rypka, Miroslav
    Vesely, Jaroslav
    ACTA BIOCHIMICA POLONICA, 2010, 57 (02) : 209 - 215
  • [36] Structural Basis for the Improved Potency of Peroxisome Proliferator-Activated Receptor (PPAR) Agonists
    Peng, Yi-Hui
    Coumar, Mohane Selvaraj
    Leou, Jiun-Shyang
    Wu, Jian-Sung
    Shiao, Hui-Yi
    Lin, Chia-Hui
    Lin, Wen-Hsing
    Lien, Tzu Wen
    Chen, Xin
    Hsu, John T. -A.
    Chao, Yu-Sheng
    Huang, Chien-Fu
    Lyu, Ping-Chiang
    Hsieh, Hsing-Pang
    Wu, Su-Ying
    CHEMMEDCHEM, 2010, 5 (10) : 1707 - 1716
  • [37] Inhibition of eosinophil survival by peroxisome proliferator-activated receptor (PPAR) alpha agonists
    Adachi, T.
    Ueki, S.
    Nagase, H.
    Chihara, J.
    Ohta, K.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S217 - S217
  • [38] Indenone derivatives:: A novel template for peroxisome proliferator-activated receptor γ (PPARγ) agonists
    Ahn, Jin Hee
    Shin, Mi Sik
    Jung, Sun Ho
    Kang, Seung Kyu
    Kim, Kwang Rok
    Rhee, Sang Dal
    Jung, Won Hoon
    Yang, Sung Don
    Kim, Seung Jun
    Woo, Joo Rang
    Lee, Jeong Hyung
    Cheon, Hyae Gyeong
    Kim, Sung Soo
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (15) : 4781 - 4784
  • [39] Diabetes: New conductors for the peroxisome proliferator-activated receptor γ (PPARγ) orchestra
    Whitehead, Jonathan P.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2011, 43 (08): : 1071 - 1074
  • [40] Expression of peroxisome proliferator-activated receptor gamma (PPAR-γ) in canine nasal carcinomas
    Paciello, O.
    Borzacchiello, G.
    Varricchio, E.
    Papparella, S.
    JOURNAL OF VETERINARY MEDICINE SERIES A-PHYSIOLOGY PATHOLOGY CLINICAL MEDICINE, 2007, 54 (08): : 406 - 410
12345